Vir Biotechnology
VIR
8.39
-0.48
-5.41%
Vir Biotechnology
US · VIR
#2824 by market cap
Listed 2019
8.39
-0.48
-5.41%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 8 analysts
Buy
Avg price target 22.43 +167.3%
Price target rangecurrent 8.39
Low17.00
Avg22.43
High30.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Barclays | -- | Buy | 30.00 |
| 2026-11-10 | Morgan Stanley | -- | Buy | 28.00 |
| 2026-11-10 | Evercore | -- | Buy | 25.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-11-09 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-11-06 | BofA Securities | -- | Buy | 17.00 |
| 2026-11-05 | TD Cowen | -- | Buy | -- |
| 2026-11-05 | Morgan Stanley | -- | Buy | 25.00 |
| 2026-11-05 | Evercore | -- | Buy | 22.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 17.00 |
| 2026-11-05 | Barclays | -- | Buy | 30.00 |
| 2026-11-04 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-11-03 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-10-19 | Barclays | -- | Buy | 30.00 |
| 2026-10-15 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-10-14 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-10-08 | Barclays | -- | Buy | 30.00 |
| 2026-10-07 | H.C. Wainwright | -- | Buy | 22.00 |
| 2026-09-29 | Leerink Partners | -- | Buy | 17.00 |
| 2026-09-28 | Needham | -- | Buy | 18.00 |
| 2026-09-21 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-08-10 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-08-07 | BofA Securities | -- | Buy | 15.00 |
| 2026-08-06 | Morgan Stanley | -- | Buy | 25.00 |
| 2026-08-06 | Evercore | -- | Buy | 22.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | After close | ±12.79% | -6.37% (in line) |
| 2026/Q2 | 2026-08-05 | After close | ±13.96% | -3.79% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±13.51% | -9.91% (in line) |
| 2025/Q4 | 2026-02-23 | After close | ±26.85% | +27.73% (beat) |
| 2025/Q3 | 2025-11-05 | After close | ±26.19% | -5.19% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±11.42% | -14.37% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±18.72% | -3.57% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±24.92% | -11.85% (in line) |
| 2024/Q3 | 2024-10-31 | After close | ±14.02% | +23.63% (beat) |
| 2024/Q2 | 2024-08-01 | After close | ±15.66% | -5.34% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±19.00% | +13.18% (in line) |
| 2023/Q4 | 2024-02-22 | After close | ±21.56% | +11.94% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Vir Biotechnology discussion 0 comments